jrnls.org logo
Submit

BROWSE ALL JOURNALS

SEE ALL 19 JOURNALS
Journal of Young PharmacistsNOW IN
Article

Nasal congestion with iloperidone therapy in a case series

Saibal Das1, Indranil Saha2, Somnath Mondal3,4★, Sanjib Bandyopadhyay5★ Corresponding author

  1. 1Nalmuri Block Primary Health Centre, West Bengal 743 502, INDIA.
  2. 2Department of Psychiatry, Medical College, Kolkata 700 073, INDIA.
  3. 3Indian Pharmacopoeia Commission, Ministry of Health and Family Welfare, Government of India, Ghaziabad 201 002, INDIA.
  4. 4Department of Clinical and Experimental Pharmacology, Calcutta School of Tropical Medicine, Kolkata 700 073, INDIA.
  5. 5Department of Community Medicine, Burdwan Medical College and Hospital, West Bengal 713 104, INDIA.

CORRESPONDENCE

Somnath Mondal

Indian Pharmacopoeia Commission, Ministry of Health and Family Welfare, Government of India, Ghaziabad 201 002, INDIA.

somu1159@gmail.com

Received: 30-06-2013; Revised: 05-07-2013; Accepted: 07-09-2013.

Volume 5, Issue 3 · pp. 108–109 · PUBLISHED · DOI: 10.1016/j.jyp.2013.08.003

View on JYP original site ↗

ABSTRACT

Iloperidone or 40-[3-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino] propoxy]-30-methoxyacetophenone is an atypical psychotropic agent belonging to piperidinyl-benzisoxazole derivative, having marked antagonistic actions on adrenergic, serotonergic, and dopaminergic receptors. It is an excellent emerging drug in anxiety and schizophrenia, and particularly useful in acute stages due to involvement of single nucleotide polymorphism in action.

KEYWORDS

    Open in new tab

    REFERENCES

    As published

    Showing references and in-text citations exactly as published.

      Cite this article

      SELECT FORMAT

      Das, S., Saha, I., Mondal, S., & Bandyopadhyay, S. (). Nasal congestion with iloperidone therapy in a case series. Journal of Young Pharmacists, 5(3), 108–109. https://doi.org/10.1016/j.jyp.2013.08.003